Études animales et cellulaires
Les données publiées proviennent d'animaux et de cellules. Peu ou aucun essai contrôlé chez l'humain n'a été publié.
Cette page est une ébauche
The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.
Quelle est la solidité des preuves
Jusqu'où il a grimpé
Chaque médicament gravit la même échelle. La plupart des composés n'atteignent jamais le sommet, et la position d'un composé indique la solidité de ses allégations.
- Médicament autorisé
Une autorité de réglementation a examiné les essais et l'a autorisé pour un usage précis.
- Phase 3
Grands essais randomisés, souvent des milliers de personnes, contre placebo ou traitement de référence.
- Phase 2
Essais de taille moyenne qui mesurent l'effet en fonction de la dose chez des personnes atteintes de la maladie.
- Phase 1 et premières études chez l'humain
Premières études chez l'humain : innocuité et manière dont l'organisme le traite.
- Cellules et animaux: CJC-1295 (No DAC)
Travaux en laboratoire et sur animaux. Un résultat chez l'animal n'est pas un résultat chez l'humain.
- 35
- articles sur PubMed
- 22
- dont chez l'humain
- 1
- essais randomisés
- 11
- revues
Un nombre indique la quantité de publications, et non ce qu'elles ont trouvé. Compté sur PubMed : 2026-11-16
Manipulation et reconstitution
De la poudre à un échantillon mesuré
Les mêmes quatre étapes pour tout flacon lyophilisé. Manipulation en laboratoire, et non utilisation chez une personne.
1. Lire le flacon
L'étiquette indique la masse de peptide contenue dans le flacon, en milligrammes. Ce nombre est le point de départ de chaque calcul.
2. Ajouter le diluant
Un volume mesuré de diluant est versé lentement, le long de la paroi du verre. Faites tourner doucement ; secouer peut endommager un peptide.
3. Calculer la concentration
La concentration est la masse divisée par le volume : 10 mg dans 2 mL donnent 5 mg par mL.
4. Mesurer l'échantillon
Le volume est la masse souhaitée divisée par la concentration. Sur une seringue U-100, 1 mL correspond à 100 unités.
Le calculateur ci-dessous effectue le calcul et montre son raisonnement.
As powder
General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.
In solution
Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.
This is general practice for lyophilized peptides, not data on CJC-1295 (No DAC) itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage
Reconstitution calculator
Opens on vial sizes common for research peptides. Change any number. How the arithmetic works
Draw to
10 units
0.1 mL on a U-100 syringe
- Concentration
- 2.5 mg/mL
- Each unit holds
- 25 mcg
- Samples in the vial
- 20
- Sample
- 250 mcg
5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of CJC-1295 (No DAC); no amount here is a recommendation.
CJC-1295 (No DAC): sur PubMed
What PubMed held for CJC-1295 (No DAC) on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.
- 35
- papers
- 22
- in humans
- 2
- clinical trials
- 1
- randomized trials
Most relevant on PubMed
Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Randomized trialTeichman SL, Neale A, Lawrence B, et al. The Journal of clinical endocrinology and metabolism, 2006. PMID 16352683
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
TrialIonescu M, Frohman LA The Journal of clinical endocrinology and metabolism, 2006. PMID 17018654
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
ReviewMayfield CK, Bolia IK, Feingold CL, et al. The American journal of sports medicine, 2026. PMID 41476424
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
ReviewRahman OF, Lee SJ, Seeds WA Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
ReviewMendias CL, Awan TM Sports medicine (Auckland, N.Z.), 2026. PMID 41966639
- Advances in the detection of growth hormone releasing hormone synthetic analogs
StudyMemdouh S, Gavrilović I, Ng K, et al. Drug testing and analysis, 2021. PMID 34665524
- Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects
StudySackmann-Sala L, Ding J, Frohman LA, et al. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2009. PMID 19386527
Search used: ("CJC-1295"[tiab] OR "CJC 1295"[tiab]). Run it on PubMed
Liens de recherche
- PubMed (opens in a new tab)Every indexed paper, newest first
- ClinicalTrials.gov (opens in a new tab)Registered trials and their status
- Europe PMC (opens in a new tab)Full text where it is open access
- Google Scholar (opens in a new tab)Papers, preprints and who cites them
- PubChem (opens in a new tab)Structure, identifiers and properties
- YouTube (opens in a new tab)Talks and lectures. Check who is speaking
These open a search for CJC-1295 (No DAC) on each site. The wiki has not reviewed what they return: a video or a preprint is not a peer-reviewed result, and none of it is medical advice.
Also in GH axis
Sold in blends: CJC-1295 (No DAC) + Ipamorelin, GHRP-2 + GHRP-6 + CJC-1295 (No DAC), Ipamorelin + CJC-1295 (No DAC) + IGF-1 LR3, Tesamorelin + Ipamorelin + CJC-1295 (No DAC)